Project Grant R21MH134756
- This Project Grant award from the National Institutes of Health (NIH) Trans-NIH Research Support program (CFDA 93.310) totaling $200,000 provides funding from March 2025 to January 2030 to evaluate the use of a machine learning algorithm-based implementation strategy for a comprehensive care management and care coordination (CCM/CC) intervention to improve HIV care continuum outcomes. The primary goal is to utilize a predictive algorithm developed by the community-based partner Comprehensive...
- This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), supports research to identify key engagement characteristics that can enhance the effectiveness of digital HIV interventions for at-risk youth. The $457,596 award to the University of Pennsylvania will fund a study that aims to: 1) harmonize engagement data from multiple Adolescent Medicine Trials Network for HIV Interventions (ATN) - UNC/Emory Center for...
- This Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $793,247 to the University of North Carolina at Chapel Hill to conduct research aimed at improving the health of people living with HIV across the lifespan. The key products and services to be delivered include: Developing and implementing a data-driven algorithm to assign validated causes for hospitalizations among people with HIV, and using...
- This Project Grant award from the National Institute of Mental Health (CFDA 93.242 - Mental Health Research Grants) will test the impact of a Basic Income Guarantee (BIG) program on viral suppression and clinic engagement for young people living with HIV in Chicago. The $819,998 award will: 1) Provide $500 monthly payments through a randomized controlled trial comparing BIG recipients to a treatment-as-usual group; 2) Assess the effects of BIG on viral suppression, clinic engagement, income...
- The University of Chicago received a $1,383,791 Project Grant award from the National Institutes of Health (NIH) Trans-NIH Research Support program (CFDA 93.310) to integrate a pharmacy technician-based model for delivering long-acting injectable cabotegravir-rilpivirine (LA-CAB/RPV) HIV treatment into community-based Federally Qualified Health Centers (FQHCs) that serve underserved people living with HIV. The overarching goal is to adapt and test this model in five FQHC clinics in Chicago,...
- The National Institute of Mental Health (NIMH) awarded a $733,355 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to the University of Alabama at Birmingham (UAB) to evaluate social brain health in people living with HIV. The project, titled "Evaluating Social Brain Health in HIV: An RDoC-Based Approach," will investigate the complex set of social cognitive abilities, including recognizing social cues and inferring others' mental states, which are crucial...
- This federal Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $653,677.00 to the University of California, Los Angeles (UCLA) to implement a cluster randomized control trial (CRCT) to test the impact of a long-term, dynamic choice intervention on 12-month viral suppression for individuals with HIV treatment interruption in Malawi. The project, titled "Ongoing Dynamic Choice to Address HIV...
- This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will support a study to evaluate field-based delivery of long-acting injectable antiretroviral therapy (LAI) for persons with HIV who are out of care in North Carolina. The $684,765 award, made on September 23, 2025, will fund a 3-year study conducted by the University of North Carolina at Chapel Hill. The study aims to examine the determinants,...
- The National Institute of Mental Health (NIMH) awarded a $3,613,504 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to the Icahn School of Medicine at Mount Sinai (ISMMS) on September 22, 2025. This 4-year grant aims to investigate the role of the NLRP3 inflammasome in HIV-induced neuroinflammation and its impact on HIV persistence in the central nervous system (CNS). The project has three key objectives: 1) Elucidate the link between HIV-1 infection and NLRP3...
- This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $334,588 to the Beth Israel Deaconess Medical Center (BIDMC) from April 1, 2025 to March 31, 2027. The project, titled "HIVE MIND: Harnessing Collective Intelligence for Predicting Clinical High-Risk for Psychosis Outcomes," aims to develop and refine predictive analytical methods, leveraging artificial intelligence and collective...
This $452,376 Project Grant awarded by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) supports research to develop a predictive model for identifying HIV patients at risk of disengaging from medical care. The University of Chicago is conducting this 2-year project, which has two key objectives: Determine the performance of a Natural Language Processing (NLP) model for predicting loss to follow-up (LTFU) from HIV care across different patient clinical phenotypes. Prospectively validate the NLP predictive model and compare its performance to clinician intuition regarding LTFU risk. The goal is to create an automated tool that can identify HIV patients most vulnerable to falling out of care, enabling targeted retention interventions. This effort aims to improve HIV treatment outcomes and contribute to ending the HIV epidemic in the United States.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $452.4k | 9/5/23 |